The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases

International Angiology

Volumn 25, Issue 2, 2006, Pages 221-227

  Rychlik Golema, W ^a   Mastej, K ^a   Adamiec, R ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytokines; Endothelin 1; Raynaud's phenomenon

Indexed keywords

ANTINUCLEAR ANTIBODY; CYTOKINE; ENDOTHELIN 1; GRANULOCYTE ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; THROMBOCYTE FACTOR 4; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COLD; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROVOCATION TEST; RAYNAUD PHENOMENON; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VENOUS BLOOD; VOLUNTEER;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CONNECTIVE TISSUE DISEASES; CYTOKINES; DISEASE PROGRESSION; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PLATELET FACTOR 4; RAYNAUD DISEASE; RECEPTORS, INTERLEUKIN-6; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; VON WILLEBRAND FACTOR;

EID: 33745929609     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Siciska J, Rudnicka L. Objaw i choroba Raynauda. In: Pasierski T, editor. Angiologia. Warszawa: PZWL; 2004.p.407-13.
2. Zapalski S. Zaburzenia naczynioruchowe. In: Noszczyk W, editor. Chirurgia tetnic i zyl obwodowych. Warszawa: PZWL 1998.p.525-41.
3. Tan RN, Cohen AS, Fress JF. The 1982 revised criteria fot classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
4. Decker JL. American Rheumatism Association nomenclature and classification of arthritis and rheumatism (1983). Arthritis Rheum 1983;26:1029-32.
5. Kotyla PJ, Sliwinska-Kotyla B, Kucharz EJ. [Structure, metabolism biological function and clinical role of endothelins]. Postepy Hig Med Dosw 1993;47:345-64.
6. Miturzynska-Stryjecka H, Horubala-Bielak G. [Endothelin: a hormone of the vascular endothelium]. Wiad Lek 1992;45:603-5.
7. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 1991;84:1457-68.
8. Wigley FM, Wise RA, Malamet R. Nicardipine in the treatment of Rynauds phenomenon. Arthritis Rheum 1987;30:281-5.
9. Haczyski J. Czynno wydzielnicza rodb onka naczy. Postepy Hig Med Dosw 1996;5:121-7.
10. Kon V, Fogo A. Endothelin: potential role in development and disease. Pediatr Nephrol 1993;7:876-80.
11. Bunker CB, Goldsmith PC, Leslie TA, Hayes N, Foreman JC, Dowd PM. Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon. Br J Dermatol 1996;134:399-406.
12. Hirata Y, Takkagi Y, Fukuda Y. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225-8.
13. Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997;15:163-7.
14. Leppert J, Ringqvist A, Karlberg BE, Ringqvist I. Whole-body cooling increases plasma endothelin-1 levels in women with primary Raynaud's phenomenon. Clin Physiol 1998;18:420-5.
15. Smith PJ, Ferro CJ, McQueen DS, Webb DJ. Functional studies in small arteries do not support a primary role for endothelin in the pathogenesis of Raynaud's disease. J Cardiovasc Pharmacol 1998;31 Suppl 1:S473-6.
16. Smyth AE, Bell AL, Bruce IN, McGrann S, Allen JA. Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud's phenomenon. Ann Rheum Dis 2000;59:870-4.
17. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol 1992;10:295-331.
18. Rychlik W, Mastej K, Adamiec R. Udzia endoteliny 1 oraz wybranych cytokin w rozwoju pierwotnego idiopatycznego fenomenu Raynaud. Adv Clin Exp Med. In press 2005.
19. Herrick AL. Vascular function in systemic sclerosis. Curr Opin Rheumatol 2000;12:527-33.
20. Medsger TA. Assessment of demage and activity in systemic sclerosis. Curr Opin Rheumatol 2000;12:545-8.
21. Nerem RM. Hemodynamic and the vascular endothelium. J Biochem Eng 1999;112:1018.
22. Scharffetter K, Buttgeeret BL, Krieg T. Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest 2000;18:999-1017.
23. Kahaleh MB. Endothelin: an endothelial-dependent vasoconstrictor in sclerodermia. Arthritis Rheum 1991;34: 978-83.
24. Siminiak T, Wysocki H. [Endothelin. II. The role of endothelin in the pathogenesis of disease]. Przegl Lek 1994;51:527-30.
25. Ewert BH, Jennette JC, Falk RJ. The pathogenic role of antineutrophil cytoplasmic autoantibodies. Am J Kidney Dis 1991;18:188-95.
26. Halim A, Kanayama N, Maradny E. Endothelin-1 inceased immunoreactive von Willebrandt factor in endothelin cells and induced micro thrombosis in rats. Thromb Res 1994;76:71-8.
27. Matsuda J, Tsukamato M, Kengo G. Effect of total body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon. Acta Haematol 2000;88:189-93.